Integrated multi-omics profiling identifies an immunotherapy vulnerable and prognostic associated subtype in cholangiocarcinoma
会议论文
编号:
3839B070F13AC1685F1058B1B14AB893
作者:
Chen, Lu[1]Tian, Xiangdong[1]
语种:
英文
会议名称:
CANCER RESEARCH
收录:
推荐引用方式 GB/T 7714:
Chen Lu,Tian Xiangdong, et al. Integrated multi-omics profiling identifies an immunotherapy vulnerable and prognostic associated subtype in cholangiocarcinoma [J].CANCER RESEARCH,2026,86(7).
APA:
Chen Lu,Tian Xiangdong.(2026).Integrated multi-omics profiling identifies an immunotherapy vulnerable and prognostic associated subtype in cholangiocarcinoma .CANCER RESEARCH,86(7).
MLA:
Chen Lu, et al. "Integrated multi-omics profiling identifies an immunotherapy vulnerable and prognostic associated subtype in cholangiocarcinoma" .CANCER RESEARCH 86,7(2026).